Journal of Health, Population and Nutrition (Oct 2023)

Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans

  • You-Yuan Yuan,
  • Wen-Dong Cao,
  • Xiao-Hong Zhang,
  • Rong-Xin Du,
  • Xue-Qi Wang,
  • Jing Li,
  • Juan Chen,
  • Jun-Zi Yang,
  • Jia-Qi Chen

DOI
https://doi.org/10.1186/s41043-023-00454-7
Journal volume & issue
Vol. 42, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Objective To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). Methods The E-coach chronic disease management model was constructed based on a literature review and expert interviews. The effect of the E-coach model on patients with ASO during hospitalisation was analysed by comparing the compliance rates of blood glucose control, blood pressure control, drug compliance, ankle-brachial index, 6-min walking test (6MWT) and pain-free walking distance (PFWD) scores between the E-coach and control groups. Results In total, 212 patients with ASO were included in this study. After the intervention, the blood pressure compliance rate (44.8% vs. 65.7%) and blood glucose compliance rate (48.6% vs. 66.8%) were higher in the E-coach group than in the control group (p < 0.05). After intervention, compared with the control group, the patients in the E-coach group had better drug compliance (6.8 ± 1.9 vs. 7.9 ± 1.0), and the difference was statistically significant (p < 0.05). The scores for the 6MWT (329.19 ± 5.58 vs. 353.00 ± 9.76; 412.65 ± 12.59 vs. 499.16 ± 18.43) and PFWD (219.15 ± 11.96 vs. 225.36 ± 16.13; 331.62 ± 51.36 vs. 369.42 ± 75.71) tests were significantly higher in the E-coach group than in the control group at 1 and 6 months after intervention (p < 0.05). Conclusion The E-coach chronic disease management model can effectively improve the control rates of blood glucose and blood pressure and the behaviour management of patients with ASO and is thus worthy of clinical reference.

Keywords